De Novo Primary Squamous Cell Carcinoma of the Prostate: Substantial Tumor Regression After Definitive Radiotherapy in a Medically Inoperable Patient
Life · 22.04.2026 · 16 (5) · 702
DOI: 10.3390/life16050702 ↗Kurz gefasst
Fallbericht in der Zeitschrift Life, online erschienen am 22.04.2026. Verfasst von Sang Jun Byun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary squamous cell carcinoma (SCC) of the prostate is a rare and biologically aggressive malignancy lacking a standardized management strategy. De novo primary SCC arising without prior androgen deprivation therapy or radiotherapy is uncommon and presents significant diagnostic and therapeutic challenges. We present the clinical presentation, diagnostic evaluation, treatment strategy, and early therapeutic response of de novo primary SCC of the prostate in a 56-year-old male with end-stage renal disease on maintenance hemodialysis. The patient presented with gross hematuria and a bulky prostate mass invading the bladder with bilateral pelvic lymphadenopathy despite low prostate-specific antigen (PSA) levels. Histopathological and immunohistochemical analyses confirmed pure SCC, staged as cT4N1M0. Because systemic chemotherapy was contraindicated and surgery was not feasible, definitive whole-pelvis radiotherapy with a simultaneous integrated boost was administered. Marked tumor regression was observed one month after treatment. Subsequent imaging demonstrated extensive tumor necrosis with fistulous communication in the context of locally invasive disease. Because long-term oncologic durability could not be assessed owing to non-oncologic clinical deterioration, these findings suggest that definitive radiotherapy may provide meaningful locoregional tumor control in selected medically inoperable patients with de novo prostatic SCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
- Department of Radiation Oncology, Keimyung University Dongsan Hospital, Daegu 42601, Republic of Korea.
- Department of Pathology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
- Department of Internal Medicine, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
- Department of Urology, Keimyung University School of Medicine, Daegu 42601, Republic of Korea.
- Department of Urology, Keimyung University Dongsan Hospital, Daegu 42601, Republic of Korea.
ORCID-Profile: Sang Jun Byun, Jin Young Kim, Seung Gyu Park, Euncheol Choi, Sang Hee Youn, Myeongsoo Kim, Byungyong Kim, Byungwook Choi
Zitieren
APA
Byun, S. J., Choe, M., Kim, J. Y., Kim, B. H., Jang, H. C., Park, S. G., Choi, E., Youn, S. H., Kim, M., Kim, B., & Choi, B. (2026). De Novo Primary Squamous Cell Carcinoma of the Prostate: Substantial Tumor Regression After Definitive Radiotherapy in a Medically Inoperable Patient. Life, 16(5), 702. https://doi.org/10.3390/life16050702
Vancouver
Byun SJ, Choe M, Kim JY, Kim BH, Jang HC, Park SG, et al. De Novo Primary Squamous Cell Carcinoma of the Prostate: Substantial Tumor Regression After Definitive Radiotherapy in a Medically Inoperable Patient. Life. 2026;16(5):702. doi:10.3390/life16050702
BibTeX
@article{Byun2026,
author = {Byun, Sang Jun and Choe, Misun and Kim, Jin Young and Kim, Byung Hoon and Jang, Hyun Chan and Park, Seung Gyu and Choi, Euncheol and Youn, Sang Hee and Kim, Myeongsoo and Kim, Byungyong and Choi, Byungwook},
title = {De Novo Primary Squamous Cell Carcinoma of the Prostate: Substantial Tumor Regression After Definitive Radiotherapy in a Medically Inoperable Patient},
journal = {Life},
year = {2026},
volume = {16},
number = {5},
pages = {702},
doi = {10.3390/life16050702}
}
EUVIMED